Literature DB >> 15207832

The pathogenesis of glycosphingolipid storage disorders.

Luba Ginzburg1, Yaacov Kacher, Anthony H Futerman.   

Abstract

Glycosphingolipid storage disorders are inborn errors of metabolism caused by the defective activity of degradative enzymes in lysosomes. In this review, we summarize studies performed over the past few years attempting to define the secondary and down-stream biochemical and cellular pathways affected in GSL storage disorders that are responsible for neuronal dysfunction, a characteristic of most of these disorders. We focus mainly on the regulation of intracellular calcium homeostasis and phospholipid biosynthesis. These studies may help unravel new roles for glycosphingolipids in the regulation of normal cell physiology, as well as suggest potential new therapeutic options in the glycosphingolipid and other lysosomal storage disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207832     DOI: 10.1016/j.semcdb.2004.03.003

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  19 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

Review 2.  Glycosphingolipidoses: beyond the enzymatic defect.

Authors:  Annick Raas-Rothschild; Irene Pankova-Kholmyansky; Yaacov Kacher; Anthony H Futerman
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  Occurrence of an anomalous endocytic compartment in fibroblasts from Sandhoff disease patients.

Authors:  Brunella Tancini; Alessandro Magini; Loredana Latterini; Lorena Urbanelli; Virginia Ciccarone; Fausto Elisei; Carla Emiliani
Journal:  Mol Cell Biochem       Date:  2009-10-02       Impact factor: 3.396

Review 4.  Invertebrate models of lysosomal storage disease: what have we learned so far?

Authors:  Samantha Hindle; Sarita Hebbar; Sean T Sweeney
Journal:  Invert Neurosci       Date:  2011-10-25

Review 5.  Yeast sphingolipids: recent developments in understanding biosynthesis, regulation, and function.

Authors:  L Ashley Cowart; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2006-08-10

Review 6.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

7.  Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage.

Authors:  Pramod K Mistry; Jun Liu; Mei Yang; Timothy Nottoli; James McGrath; Dhanpat Jain; Kate Zhang; Joan Keutzer; Wei-Lien Chuang; Wei-Lein Chuang; Wajahat Z Mehal; Hongyu Zhao; Aiping Lin; Shrikant Mane; Xuan Liu; Yuan Z Peng; Jian H Li; Manasi Agrawal; Ling-Ling Zhu; Harry C Blair; Lisa J Robinson; Jameel Iqbal; Li Sun; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

Review 8.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

Review 9.  Pathogenic cascades in lysosomal disease-Why so complex?

Authors:  S U Walkley
Journal:  J Inherit Metab Dis       Date:  2009-01-07       Impact factor: 4.982

Review 10.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.